Pricing Log in Create free account

Artelo Biosciences, Inc. (ARTL) vs Moolec Science SA (MLEC)

Artelo Biosciences, Inc. and Moolec Science SA are both Biotechnology companies. Artelo Biosciences, Inc. is the larger, with a market value of $1.5M against $1.4M — 1.1× the size. Artelo Biosciences, Inc. has the higher net margin (0.00% vs −7.18%) and the lower return on invested capital (−865.9% vs 0.00%). Across the 14 metrics below, Moolec Science SA leads on 8 and Artelo Biosciences, Inc. on 6.

Valuation

Metric ARTL MLEC Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.00 9.71
P/B 0.16 0.03 2.13
Price to free cash flow n/m 0.02 20.82
EV/EBITDA 0.31 1.76 0.64
EV/Sales n/m 0.14 9.21
Earnings yield (4,348.52%) (4,665.32%) (33.15%)
Free cash flow yield (1,553.13%) 4,200.26% (25.50%)

Profitability

Metric ARTL MLEC Biotechnology median
Gross margin 0.00% 39.67% 65.16%
Operating margin 0.00% 4.09% 0.00%
Net margin 0.00% (7.18%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (705.71%) 0.00% (56.36%)
Return on assets (234.30%) 0.00% (48.04%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL MLEC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 31.57% (447.53%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL MLEC Biotechnology median
Debt to equity 0.00 4.37 0.00
Current ratio 3.00 0.15 4.72
Net debt to EBITDA 0.05 (2.73) 0.96

Dividend

Metric ARTL MLEC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARTL MLEC Biotechnology median
Market cap 1.50m 1.36m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack